Professor Salome Charalambous

I mean, I think that it starts from the person that is ill.

And the whole thing is that when there are limited resources, it's quite difficult for people to even just access care.

So even to just make it to a clinic

You know, if there isn't money for transportation, for instance, or if there isn't money, if there is a copayment required or treatment payment required, which in many countries that is the case, people just don't even access care.

And once they get to a clinic, if there's not enough nurses and healthcare workers and they have to sit in a queue for an entire day and are unable to

to earn money while they're in the queue or even to have someone you know look after their children while they're in the queue that's another big problem and then you know then then once you're in the in in the healthcare setting you have the problems of what what kind of tests are available to those healthcare workers

If they do a test that requires something to be sent to a laboratory, for instance, are there resources to get that test to a laboratory to be tested?

Are there resources to get the result back to the healthcare worker?

Once the healthcare worker has a result, you know, and say the result is negative, have they got access to other tests to try and understand what is actually going on with this person?

And if it's positive, have they got the treatment available?

So has the country got that treatment for, in some cases, the country hasn't even purchased the treatment because it's

It's too expensive.

Or if they have purchased a treatment, have they actually got it to the place where the person is?

Because every time, you know, if someone has started on TB treatment, for instance, sometimes people actually expect the person for the first two weeks to go every single day back to the clinic to take a medication.

you know, that's called directly observed treatment.

And, you know, I think for a long time, that is how that was the mainstay of how people gave TB treatment, for instance.

But now everyone has understood that that just creates even more barriers for the person who's on treatment.

I mean, you know, there's so many, so many challenges.

And, you know, I think that a lot of the

the programs and the global health community have understood that there are these challenges and the only way to get past some of these challenges is by supporting and supporting in all the ways that we've spoken about.